When it comes to managing urge incontinence, anticholinergics like solifenacin and oxybutynin can cause confusion in elderly patients, making them less suitable for those with cognitive impairment. Instead, mirabegron, a beta-3 adrenergic agonist, is a better alternative that can effectively treat urge incontinence without the risk of anticholinergic side effects. Long-term catheterisation and fluid restriction should not be considered as viable options for managing incontinence.

Urinary incontinence is a common condition that affects approximately 4-5% of the population, with elderly females being more susceptible. There are several risk factors that can contribute to the development of urinary incontinence, including advancing age, previous pregnancy and childbirth, high body mass index, hysterectomy, and family history. The condition can be classified into different types, such as overactive bladder, stress incontinence, mixed incontinence, overflow incontinence, and functional incontinence.

Initial investigation of urinary incontinence involves completing bladder diaries for at least three days, performing a vaginal examination to exclude pelvic organ prolapse, and conducting urine dipstick and culture tests. Urodynamic studies may also be necessary. Management of urinary incontinence depends on the predominant type of incontinence. For urge incontinence, bladder retraining and bladder stabilizing drugs such as antimuscarinics are recommended. For stress incontinence, pelvic floor muscle training and surgical procedures may be necessary. Duloxetine, a combined noradrenaline and serotonin reuptake inhibitor, may also be offered to women who decline surgical procedures.

In summary, urinary incontinence is a common condition that can be caused by various risk factors. It can be classified into different types, and management depends on the predominant type of incontinence. Initial investigation involves completing bladder diaries, performing a vaginal examination, and conducting urine tests. Treatment options include bladder retraining, bladder stabilizing drugs, pelvic floor muscle training, surgical procedures, and duloxetine.

Coeliac Disease and Selective IgA Deficiency

Coeliac disease is more common in individuals with selective IgA deficiency, which affects 0.4% of the general population and 2.6% of coeliac disease patients. Diagnosis of coeliac disease relies on detecting IgA antibodies to transglutaminase or anti-endomysial antibody. However, it is crucial to check total serum IgA levels before ruling out the diagnosis based on serology. For those with confirmed IgA deficiency, IgG tTGA and/or IgG EMA are the appropriate serological tests.

A returning traveller presenting with retro-orbital headache, fever, facial flushing, rash, and thrombocytopenia is likely to have dengue fever. The characteristic low platelet count and elevated transaminase level support this diagnosis. The 2019 RCGP Curriculum includes Fever in the returning traveller and its possible causes, such as malaria, dengue, typhoid/paratyphoid, chikungunya, and viral haemorrhagic fevers, in its Knowledge and skills guide.

Understanding Dengue Fever

Dengue fever is a viral infection that can lead to viral haemorrhagic fever, which includes diseases like yellow fever, Lassa fever, and Ebola. The dengue virus is an RNA virus that belongs to the Flavivirus genus and is transmitted by the Aedes aegypti mosquito. The incubation period for dengue fever is seven days.

Patients with dengue fever can be classified into three categories: those without warning signs, those with warning signs, and those with severe dengue (dengue haemorrhagic fever). Symptoms of dengue fever include fever, headache (often retro-orbital), myalgia, bone pain, arthralgia (also known as ‘break-bone fever’), pleuritic pain, facial flushing, maculopapular rash, and haemorrhagic manifestations such as a positive tourniquet test, petechiae, purpura/ecchymosis, and epistaxis. Warning signs include abdominal pain, hepatomegaly, persistent vomiting, and clinical fluid accumulation (ascites, pleural effusion). Severe dengue (dengue haemorrhagic fever) is a form of disseminated intravascular coagulation (DIC) that results in thrombocytopenia and spontaneous bleeding. Around 20-30% of these patients go on to develop dengue shock syndrome (DSS).

Typically, blood tests are used to diagnose dengue fever, which may show leukopenia, thrombocytopenia, and raised aminotransferases. Diagnostic tests such as serology, nucleic acid amplification tests for viral RNA, and NS1 antigen tests may also be used. Treatment for dengue fever is entirely symptomatic, including fluid resuscitation and blood transfusions. Currently, there are no antivirals available for the treatment of dengue fever.

Reporting concerns about patients’ fitness to drive

It is important to take action if you have concerns about a patient’s fitness to drive. However, there are guidelines that must be followed to ensure patient confidentiality is maintained. Before contacting the DVLA, it is recommended to inform the patient of your decision to disclose personal information and then inform them in writing once you have done so. If a patient continues to drive despite being unfit to do so, every reasonable effort should be made to persuade them to stop. If this fails, the DVLA should be contacted immediately and any relevant medical information disclosed in confidence to the medical adviser.

Leaving the decision about driving to specialists is not recommended. Patients who refuse to accept a diagnosis or the effect of their condition on their ability to drive should be advised to seek a second opinion and not to drive in the meantime. If unsure about a specific case, seeking advice from the DVLA’s medical adviser is recommended.

DVLA guidance on dementia states that those with poor short-term memory, disorientation, lack of insight, and judgment are almost certainly not fit to drive. Reporting a patient to the police is not in line with current guidance. It is important to follow the guidelines to ensure patient confidentiality is maintained while taking appropriate action to ensure road safety.

Administer Benzylpenicillin IM 300 mg STAT to a child <= 11 months suspected of meningococcal disease before urgent hospital transfer. When suspected bacterial meningitis is being investigated and managed, it is important to prioritize timely antibiotic treatment to avoid negative consequences. Patients should be urgently transferred to the hospital, and if meningococcal disease is suspected in a prehospital setting, intramuscular benzylpenicillin may be given. An ABC approach should be taken initially, and senior review is necessary if any warning signs are present. A key decision is when to attempt a lumbar puncture, which should be delayed in certain circumstances. Management of patients without indication for delayed LP includes IV antibiotics, with cefotaxime or ceftriaxone recommended for patients aged 3 months to 50 years. Additional tests that may be helpful include blood gases and throat swab for meningococcal culture. Prophylaxis needs to be offered to households and close contacts of patients affected with meningococcal meningitis, and meningococcal vaccination should be offered to close contacts when serotype results are available.

Patients with severe visual impairment often have coexisting CBS and may experience recurrent, persistent, or episodic visual or auditory hallucinations. The most prevalent ophthalmological condition linked to CBS is age-related macular degeneration, making it the correct answer.

While glaucoma, cataract, and other ophthalmic conditions can also cause CBS, they are less common than age-related macular degeneration.

It is crucial to understand that these hallucinations are a result of deteriorating eyesight and not indicative of an underlying psychiatric disorder.

Understanding Charles-Bonnet Syndrome

Charles-Bonnet syndrome (CBS) is a condition characterized by complex hallucinations, usually visual or auditory, that occur in clear consciousness. These hallucinations persist or recur and are often experienced against a background of visual impairment, although this is not always the case. People with CBS typically retain their insight and do not experience any other significant neuropsychiatric disturbances.

Several factors can increase the risk of developing CBS, including advanced age, peripheral visual impairment, social isolation, sensory deprivation, and early cognitive impairment. The condition affects both sexes equally and doesn’t appear to have any familial predisposition. Age-related macular degeneration is the most common ophthalmological condition associated with CBS, followed by glaucoma and cataract.

Complex visual hallucinations are relatively common in people with severe visual impairment, occurring in 10-30% of cases. The prevalence of CBS in visually impaired individuals is estimated to be between 11 and 15%. Although some people find the hallucinations unpleasant or disturbing, CBS is typically a long-term condition, with 88% of people experiencing it for two years or more. Only 25% of people experience a resolution of their symptoms after nine years.

In summary, CBS is a condition that can cause complex hallucinations in people with visual impairment. Although the hallucinations can be distressing, most people with CBS retain their insight and do not experience any other significant neuropsychiatric disturbances. The condition is relatively common in visually impaired individuals and tends to be a long-term condition.

Antiphospholipid syndrome is the most probable diagnosis due to the paradoxical occurrence of prolonged APTT and low platelets.

Antiphospholipid syndrome is a condition that can be acquired and is characterized by a higher risk of both venous and arterial thromboses, recurrent fetal loss, and thrombocytopenia. It can occur as a primary disorder or secondary to other conditions, with systemic lupus erythematosus being the most common. One important point to remember for exams is that antiphospholipid syndrome causes a paradoxical increase in the APTT due to an ex-vivo reaction of lupus anticoagulant autoantibodies with phospholipids involved in the coagulation cascade.

Other features of antiphospholipid syndrome include livedo reticularis, pre-eclampsia, and pulmonary hypertension. It is associated with other autoimmune disorders and lymphoproliferative disorders, as well as rare cases of phenothiazines. Management of antiphospholipid syndrome is based on EULAR guidelines, with primary thromboprophylaxis and low-dose aspirin being recommended. For secondary thromboprophylaxis, lifelong warfarin with a target INR of 2-3 is recommended for initial venous thromboembolic events, while recurrent venous thromboembolic events require lifelong warfarin and may benefit from the addition of low-dose aspirin and an increased target INR of 3-4. Arterial thrombosis should also be treated with lifelong warfarin with a target INR of 2-3.

Screening for Depression: Two Questions Recommended by NICE

The National Institute for Health and Care Excellence (NICE) recommends two questions for screening depression: Have you often been bothered by having little interest or pleasure in doing things? and Have you been feeling down, depressed or hopeless? These questions relate to the past month and have a sensitivity of 96% and a specificity of 57%. While useful for screening, they are not sufficient for diagnosis.

Screening for depression is particularly important for those with a history of depression, significant physical illness, or other mental health problems like dementia. Depression and dementia can have similar symptoms, making screening crucial. Other high-risk groups include women in the puerperium, alcoholics and drug abusers, socially isolated individuals (especially the elderly), people in stressful situations, and those with unexplained symptoms.

If a patient answers yes to the screening questions, further questions about worthlessness, concentration, and thoughts of death should follow. Early detection and treatment of depression can improve outcomes and quality of life for patients.

Considerations for Drug Delivery in Palliative Care

Drug delivery is a crucial aspect to consider in palliative care, as patients may have difficulties with certain formulations or preparations. For instance, some patients may have trouble swallowing medication due to dysphagia, while others may be intolerant to specific preparations. In such cases, transdermal fentanyl and buprenorphine can be used as alternatives.

However, it’s important to note that transdermal preparations may not be suitable for patients who require treatment for acute pain or those with variable pain relief needs. This is because the route of administration affects the pharmacokinetics, resulting in a delay in achieving a steady state.

When switching from oral morphine preparations to transdermal fentanyl, the British National Formulary (BNF) provides a section on equivalent doses. For example, 60 mg daily of oral morphine equates to the fentanyl ’25’ patch. However, if the opioid problem is hyperalgesia, it’s recommended to cut the dose of the new opioid by one quarter to one half of the equivalent dose.

It’s essential to consult the palliative care section in the BNF for further details on other dose equivalencies. Fentanyl patches should be applied every 72 hours, and patients may require extra analgesia for up to 24 hours after the patch is started due to its slow onset of action. Doses of the patch can be adjusted at 72-hour intervals.

If a patient is taking a long-acting 12-hourly morphine, the patch should be applied when the last dose is given. On the other hand, if a patient is taking a short-acting morphine, it should be continued four hourly for the first 12 hours of patch use. By considering these drug delivery factors, healthcare professionals can provide effective pain relief for patients in palliative care.

Severe acne is characterized by the presence of nodules, cysts, and a high risk of scarring. It is recommended to refer patients with severe acne for specialist assessment and treatment, which may include oral isotretinoin. In the meantime, a combination of oral antibiotics and topical retinoids or benzoyl peroxide can be prescribed.

Topical antibiotics should be avoided when using oral antibiotics. Tetracycline, oxytetracycline, doxycycline, or lymecycline are the first-line antibiotic options, while erythromycin can be used as an alternative. Minocycline is not recommended.

It is not recommended to prescribe antibiotics alone or to combine a topical and oral antibiotic. Women who require contraception can be prescribed a combined oral contraceptive (COC), with a standard COC being suitable for most women. Co-cyprindiol (Dianette®) should only be considered when other treatments have failed and should be discontinued after three to four menstrual cycles once the acne has resolved.

Acne vulgaris is a common skin condition that usually affects teenagers and is characterized by the obstruction of hair follicles with keratin plugs, resulting in comedones, inflammation, and pustules. The severity of acne can be classified as mild, moderate, or severe, depending on the number and type of lesions present. Treatment for acne typically involves a step-up approach, starting with single topical therapy and progressing to combination therapy or oral antibiotics if necessary. Tetracyclines are commonly used but should be avoided in certain populations, and a topical retinoid or benzoyl peroxide should always be co-prescribed to reduce the risk of antibiotic resistance. Combined oral contraceptives can also be used in women, and oral isotretinoin is reserved for severe cases under specialist supervision. Dietary modification has no role in the management of acne.